1. Blood. 2013 May 30;121(22):4434-6. doi: 10.1182/blood-2013-04-494849.

A new era for Waldenstrom macroglobulinemia: MYD88 L265P.

Treon SP(1), Hunter ZR.

Author information:
(1)Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer 
Institute.

Comment on
    Blood. 2013 May 30;121(22):4504-11. doi: 10.1182/blood-2012-06-436329.

In this issue of Blood, Poulain et al demonstrate the high prevalence of the 
MYD88 L265P somatic mutation in patients with Waldenstrom macroglobulinemia (WM) 
and provide insight into its biological relevance in the growth and survival of 
WM.

DOI: 10.1182/blood-2013-04-494849
PMID: 23723443 [Indexed for MEDLINE]